IL4 and chronic rhinosinusitis with nasal polyps: For example, dupilumab is an anti-interleukin (IL)4Rα antagonist that prevents IL-4 and IL-13 from binding to their receptors and blocks the downstream signal transduction of the Th2 inflammatory pathway, and can be used to treat refractory CRSwNP [11].